Skip to main content

Azathioprine Tablets Shortage

Last Updated: May 26, 2016
Status: Resolved

Products Affected - Description
    • Azathioprine oral tablet, Roxane, 50 mg, 100 count, NDC 00054-4084-25
    • Azathioprine oral tablet, Roxane, 50 mg, unit-dose 100 count, NDC 00054-8084-25
Reason for the Shortage
    • Roxane discontinued azathioprine tablets in mid-January 2015 due to problems obtaining active ingredient.
    • Valeant acquired Salix Pharmaceuticals in April 2015.
    • Mylan could not provide a reason for the shortage.
    • Prometheus Laboratories states the reason for the shortage was increased demand.
Available Products
    • Azasan oral tablet, Valeant, 100 mg, 100 count, NDC 65649-0241-41
    • Azasan oral tablet, Valeant, 75 mg, 100 count, NDC 65649-0231-41
    • Imuran oral tablet, Prometheus Laboratories, 50 mg, 100 count, NDC 65483-0590-10
    • Azathioprine oral tablet, Mylan, 50 mg, unit-dose 50 count, NDC 51079-0620-06
    • Azathioprine oral tablet, Mylan, 50 mg, 100 count, NDC 00378-1005-01
    • Azathioprine oral tablet, Zydus, 50 mg, 100 count, NDC 68382-0003-01
    • Azathioprine oral tablet, Zydus, 50 mg, 500 count, NDC 68382-0003-05

Estimated Resupply Dates

    • All suppliers have product available.

Updated

Updated May 26, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 29, 2014 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer